Association between author specialty and reported outcomes in non-randomized comparisons of prostatectomy versus radiation.

IF 4.8 Q2 ONCOLOGY
Zakaria El Kouzi, Mohammed A Mohammed, Michael Kevin Rooney, Ramez Kouzy, Jie Jane Chen, Shalin Shah, Tarek Al Bitar, Sherif M Gadoue, Comron Hassanzadeh, Steven Frank, Phuoc Tho Tran, Chad Tang, Seungtaek Choi, Ryan Jin-Hyung Park, Karen Hoffman, Sean Eric McGuire, Henry Mok, Quynh-Nhu Nguyen, Adam B Samman, Zain Rahman, Mohamed Shelan, Toufic Eid, Osama Mohamad
{"title":"Association between author specialty and reported outcomes in non-randomized comparisons of prostatectomy versus radiation.","authors":"Zakaria El Kouzi, Mohammed A Mohammed, Michael Kevin Rooney, Ramez Kouzy, Jie Jane Chen, Shalin Shah, Tarek Al Bitar, Sherif M Gadoue, Comron Hassanzadeh, Steven Frank, Phuoc Tho Tran, Chad Tang, Seungtaek Choi, Ryan Jin-Hyung Park, Karen Hoffman, Sean Eric McGuire, Henry Mok, Quynh-Nhu Nguyen, Adam B Samman, Zain Rahman, Mohamed Shelan, Toufic Eid, Osama Mohamad","doi":"10.1093/jncics/pkag069","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>While the ProtecT randomized trial demonstrated comparable oncologic outcomes between radical prostatectomy (RP) and radiation therapy (RT) for localized prostate cancer, several retrospective studies have reported mixed findings. In this study, we investigated whether non-randomized studies tend to favor RP or RT and assessed whether the specialty of leading authors-urologists or radiation oncologists-correlates with study conclusions.</p><p><strong>Methods: </strong>We identified non-randomized clinical studies published between 1993 and 2024 that compared RP and RT for localized prostate cancer and reported oncologic outcomes including biochemical, metastasis, and/or survival outcomes. Author specialty was determined based on whether the first and senior authors were affiliated with urology or radiation oncology departments. Studies in which a urologist and radiation oncologist were first and senior authors were excluded. Each study's conclusion was categorized as favoring surgery, favoring radiation, or reporting no conclusive difference in oncologic outcomes. Multivariate logistic regression was used to evaluate predictors of study conclusions.</p><p><strong>Results: </strong>A total of 105 studies met inclusion criteria. Nearly half (44%) reported no conclusive difference in outcomes, while 42% favored RP and 14% favored RT. Multivariate analysis showed that use of national databases (P = .01) and urology author specialty (P = .01) predicted conclusions aligning with the author's specialty. In a subgroup excluding studies relying solely on biochemical recurrence-free survival outcomes, author specialty remained associated with conclusions, with urologists more likely to favor RP (P = .006).</p><p><strong>Conclusion: </strong>Author specialty was associated with the direction of study conclusions. Further research is needed to understand how these patterns may influence interpretation and decision-making in prostate cancer treatment.</p>","PeriodicalId":14681,"journal":{"name":"JNCI Cancer Spectrum","volume":" ","pages":""},"PeriodicalIF":4.8000,"publicationDate":"2026-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13394490/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JNCI Cancer Spectrum","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/jncics/pkag069","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: While the ProtecT randomized trial demonstrated comparable oncologic outcomes between radical prostatectomy (RP) and radiation therapy (RT) for localized prostate cancer, several retrospective studies have reported mixed findings. In this study, we investigated whether non-randomized studies tend to favor RP or RT and assessed whether the specialty of leading authors-urologists or radiation oncologists-correlates with study conclusions.

Methods: We identified non-randomized clinical studies published between 1993 and 2024 that compared RP and RT for localized prostate cancer and reported oncologic outcomes including biochemical, metastasis, and/or survival outcomes. Author specialty was determined based on whether the first and senior authors were affiliated with urology or radiation oncology departments. Studies in which a urologist and radiation oncologist were first and senior authors were excluded. Each study's conclusion was categorized as favoring surgery, favoring radiation, or reporting no conclusive difference in oncologic outcomes. Multivariate logistic regression was used to evaluate predictors of study conclusions.

Results: A total of 105 studies met inclusion criteria. Nearly half (44%) reported no conclusive difference in outcomes, while 42% favored RP and 14% favored RT. Multivariate analysis showed that use of national databases (P = .01) and urology author specialty (P = .01) predicted conclusions aligning with the author's specialty. In a subgroup excluding studies relying solely on biochemical recurrence-free survival outcomes, author specialty remained associated with conclusions, with urologists more likely to favor RP (P = .006).

Conclusion: Author specialty was associated with the direction of study conclusions. Further research is needed to understand how these patterns may influence interpretation and decision-making in prostate cancer treatment.

前列腺切除术与放疗的非随机比较中作者专业与报道结果之间的关系。
背景:虽然ProtecT随机试验显示根治性前列腺切除术(RP)和放射治疗(RT)治疗局限性前列腺癌的肿瘤学结果相当,但几项回顾性研究报告了不同的结果。在这项研究中,我们调查了非随机研究是否倾向于RP或RT,并评估了主要作者(泌尿科医生或放射肿瘤科医生)的专业是否与研究结论相关。方法:我们确定了1993年至2024年间发表的非随机临床研究,这些研究比较了RP和RT治疗局限性前列腺癌的效果,并报告了包括生化、转移和/或生存结果在内的肿瘤学结果。作者专业是根据第一作者和高级作者是否隶属于泌尿科或放射肿瘤科来确定的。排除泌尿科医生和放射肿瘤科医生为第一作者和资深作者的研究。每项研究的结论都被归类为支持手术、支持放疗或报告肿瘤结果无决定性差异。采用多因素logistic回归评价研究结论的预测因素。结果:共有105项研究符合纳入标准。近一半(44%)的患者报告结果没有结论性差异,42%的患者倾向于RP, 14%的患者倾向于rt。多变量分析显示,使用国家数据库(p = 0.01)和泌尿外科作者专业(p = 0.01)预测结论与作者专业一致。在排除仅依赖生化无复发生存结果的研究的亚组中,作者的专业仍然与结论相关,泌尿科医生更倾向于RP (p = 0.006)。结论:作者专业与研究结论的方向相关。需要进一步的研究来了解这些模式如何影响前列腺癌治疗的解释和决策。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
JNCI Cancer Spectrum
JNCI Cancer Spectrum Medicine-Oncology
CiteScore
7.70
自引率
0.00%
发文量
80
审稿时长
18 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书